Aurobindo Pharma Ltd.

In News

Aurobindo Pharma stock edges higher as US tariff risks and FDA approvals shape outlook - AD HOC NEWS

AD HOC NEWS - Sep 19, 2026

FTC requiring Aurobindo Pharma to divest from four drug products to complete acquistion of Lannett - Reuters

Reuters - Jun 18, 2026

Aurobindo Pharma Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 28, 2026

Aurobindo Pharma receives final USFDA approval for generic Beclomethasone inhalation Aerosol - Indian Pharma Post

Indian Pharma Post - Sep 16, 2026

ACQUISITIONS & MERGERS NEWS: FTC... - VitalLaw.com

VitalLaw.com - Jun 22, 2026

Aurobindo Pharma Gets USFDA Nod for First Metered-Dose Inhaler, Beclomethasone Aerosol - medicaldialogues.in

medicaldialogues.in - Sep 15, 2026

Aurobindo’s Lannett Launches Generic Advair Diskus in US Market - HDFC Sky

HDFC Sky - Aug 31, 2026

Bristol-Myers Sues Aurobindo to Block Camzyos Heart Drug Copies - Bloomberg Law News

Bloomberg Law News - Jul 14, 2026

News by CNBC TV18 on TradingView, 2026-09-11 — cnbctv:702b6f87c094b:0 - TradingView

TradingView - Sep 11, 2026

Aurobindo Pharma receives US FDA nod for metered Beclomethasone Dipropionate aerosol - Business Standard

Business Standard - Sep 15, 2026

Aurobindo Pharma’s Unit IV Clears USFDA Inspection: Shares Down - Equitypandit

Equitypandit - Sep 15, 2026

Aurobindo Pharma arm launches generic version of Advair Diskus in US - Moneycontrol.com

Moneycontrol.com - Aug 31, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment